Urinary Bladder Cancer
📧 Sign up to get email alerts when something new happens for Urinary Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Histopathological Findings in En-Bloc vs Conventional Transurethral Resection of Bladder Tumors. [NA]
The completed trial compares en-bloc versus conventional transurethral resection of bladder tumors and reports histopathological findings.
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder [Phase 2]
A Phase 2 clinical trial comparing holmium versus bipolar en bloc transurethral resection of urothelium tumors of the urinary bladder has co…
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder [Phase 2]
Phase 2 clinical trial update evaluating radio-immunotherapy before cystectomy in locally advanced urothelial carcinoma of the bladder.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder [Phase 2]
Phase 2 study evaluating neoadjuvant gemcitabine/platinum chemotherapy for muscle-invasive or locally-advanced urothelial carcinoma of the b…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. [Phase 3]
Phase 3 clinical trial investigating mitomycin C intravesical chemotherapy with Synergo radiofrequency-induced hyperthermia for Bacillus Cal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [Phase 1]
Phase 1 clinical trial evaluating the radiotracer 68Ga-NOTA-AE105 for PET-based diagnosis of aggressive cancers, including breast cancer, pr…